Improving tracking of AMR bacteria in hospitals using new genomic technique
The spread of multiple bacteria could be tracked simultaneously through sequencing method
Read More
Tag: Antimicrobial resistance
AMR testing technology from QuantaMatrix backed by research paper in Nature
The new test takes an average of 13 hours to identify the correct treatment compared to several days with current methods
Read More
Sysmex receives Longitude Prize on AMR for antimicrobial testing system
AMR is designated as one of the top ten global public health threats facing humanity by WHO
Read More
Glox Therapeutics secures £4.3m seed funding to combat AMR
The bacteriocin development programme will first target pseudomonas aeruginosa
Read More
Sandoz opens new antibiotic and biosimilar facilities in Austria and Germany
Antimicrobial resistance is considered one of the top ten global public health threats
Read More
New £30m initiative launched to support innovation against antimicrobial resistance
Global innovators can apply to PACE to receive up to £1m per project
Read More
UKRI awards £10m in funding to tackle antimicrobial resistance
UK researchers can apply to receive a share of £3m to set up transdisciplinary networks
Read More
Microplate Dx secures £2.5m for rapid diagnostic technology development
The platform will be used to advance the effectiveness of antibiotics
Read More
Phico Therapeutics raises £7m to advance next-gen antibiotic candidate
Funds will support continued development of company’s SASPject platform and progression of lead product PT3.9
Read More
Novel antibiotic Recarbrio has launched in the UK
Combination treatment scored EU approval earlier this year
Read More
Shionogi launches novel antibiotic Fetcroja in the UK
The drug is indicated for use as a treatment of infections caused by aerobic Gram-negative bacteria
Read More
Destiny Pharma’s novel antibiotic asset clears safety review
Independent Data Monitoring Committee recommended continuing Phase IIb study
Read More
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
